Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-25

Clinical Trial Update: Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant [NA]

View source ↗

Summary

Completed clinical trial comparing Ramosetron plus Aprepitant versus Palonosetron plus Aprepitant for postoperative nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aloxi (palonosetron hydrochloride)
  • EMEND (aprepitant)
  • Ramosetron (ramosetron)

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Postoperative Nausea and Vomiting | NA | Status: COMPLETED | Results posted: 2017-04-25